4.7 Article

Simultaneous activation of p53 and inhibition of XIAP enhance the activation of apoptosis signaling pathways in AML

Related references

Note: Only part of the references are listed.
Article Hematology

Analysis of the p53 and MDM-2 gene in acute myeloid leukemia

Barbara Seliger et al.

EUROPEAN JOURNAL OF HAEMATOLOGY (2010)

Review Biochemistry & Molecular Biology

The dark side of a tumor suppressor:: anti-apoptotic p53

R. U. Janicke et al.

CELL DEATH AND DIFFERENTIATION (2008)

Review Biotechnology & Applied Microbiology

Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-κB pathways

Anwesha Dey et al.

NATURE REVIEWS DRUG DISCOVERY (2008)

Article Biochemistry & Molecular Biology

Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo

A Sullivan et al.

ONCOGENE (2004)

Article Multidisciplinary Sciences

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

LT Vassilev et al.

SCIENCE (2004)

Article Chemistry, Medicinal

Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer

TK Oost et al.

JOURNAL OF MEDICINAL CHEMISTRY (2004)

Article Biochemistry & Molecular Biology

Bone marrow stroma inhibits proliferation and apoptosis in leukemic cells through gap junction-mediated cell communication

FH Paraguassú-Braga et al.

CELL DEATH AND DIFFERENTIATION (2003)

Article Biochemistry & Molecular Biology

HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins

AM Verhagen et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Article Cell Biology

Identification of XAF1 as an antagonist of XIAP anti-caspase activity

P Liston et al.

NATURE CELL BIOLOGY (2001)

Article Biotechnology & Applied Microbiology

Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines

WG Fong et al.

GENOMICS (2000)